Hybridization probes and methods

• US 10,030,268 B2
• Filed: 11/11/2015
• Issued: 07/24/2018
• Est. Priority Date: 11/11/2014
• Status: Expired due to Fees

• Current Assignee: Abbott Molecular Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Molecular Incorporated (Abbott Laboratories)
• Inventors: Russell, John, Pestova, Ekaterina, Adya, Neeraj
• Primary Examiner(s): Dauner, Joseph G.
• Application Number:
  US14/938,240
• Publication Number:
  US 20160215334A1
• Time in Patent Office: 986 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6832 Enhancement of hybridisation reaction
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 2525/155 incorporating/generating a new priming site
• CPC Class Codes: C12Q 2525/191 incorporating an adaptor
• CPC Class Codes: C12Q 2563/107 fluorescence

Abstract

The present invention relates to compositions and methods for detection, analysis, and treatment of nucleic acids. In particular, the present invention relates to compositions and methods for generating and using hybridization probes.

Claims

1. A method of generating a probe to a nucleic acid target, comprising:

a) amplifying a plurality of regions of said nucleic acid target that are at least 85% free of undesired sequences wherein said undesired sequences are at least 100 bp in length to generate amplification products in a first amplification, wherein said amplifying comprises a primer pair complementary to said plurality of regions;

b) combining said amplification products to generate a mixture;

c) isolating said amplification products in said mixture;

d) fragmenting said mixture of said isolated amplification products to generate a mixture of fragmented amplification products;

e) size fractionating said fragmented amplification products;

f) ligating said size fractionated amplification products to nucleic acid adaptors wherein said adaptors are each ligated to two or more amplification products, and wherein said adaptors comprise amplification primer sequences;

g) amplifying said amplification products comprising said adaptors to generate amplification products in a second amplification wherein said amplifying comprises a primer pair complementary to said adaptor primer sequences; and

h) labeling said amplification products generated in step g) to generate one or more said probes.

2. The method of claim 1, wherein said undesired sequences are selected from the group consisting of repeat sequences, non-conserved sequences, conserved sequences, GC rich sequences, AT rich sequences, secondary structure, and coding sequences.

3. The method of claim 2, wherein said undesired sequences are repeat sequences.

4. The method of claim 1, wherein one or more of said amplification adaptors that comprise amplification primers comprise a label, a binding site, or a restriction site.

5. The method of claim 1, wherein said regions of said nucleic acid target or said probes are from 100 to 600 bp in length.

6. The method of claim 1, wherein said regions of said nucleic acid target or said probes are 150 bp in length.

7. The method of claim 1, wherein said isolating is precipitating said amplification products.

8. The method of claim 1, wherein said fragmenting is sonication.

9. The method of claim 1, wherein said size fractionating is electrophoresis, chromatography or spin column size fractionating.

10. The method of claim 1, wherein said size fractionated amplification products of step e) are 5′

phosphorylated and/or blunt ended before step f).

11. The method of claim 1, wherein said amplification products generated in step g) are aminated.

12. The method of claim 1, wherein said labeling is fluorophore labeling.

13. The method of claim 1, further comprising i) denaturing said labeled amplification products generated in step g).

14. The method of claim 13, wherein said denaturing is formamide denaturing.